#1 Clinical Trials Search in Europe

CARBACHOL

CARBACHOL is a medication currently being investigated in various clinical trials for different medical conditions. Most notably, it is being studied as a potential treatment for presbyopia (age-related farsightedness) in eye drop formulations, and it has also been tested for its effects on headache and cerebral blood flow. This article summarizes the current clinical research involving CARBACHOL, focusing on its potential benefits, administration methods, and the ongoing studies evaluating its safety and effectiveness.

Table of Contents

What is Carbachol?

Carbachol is a medication that belongs to a class of drugs known as cholinergic agents. It acts as an analogue of acetylcholine, which is a natural chemical messenger (neurotransmitter) in your body that helps transmit signals between nerve cells[1]. The drug is also sometimes referred to as “carbachol monotherapy” when used alone, particularly in eye treatments[2].

Medical Uses of Carbachol

Based on the clinical trial data, Carbachol is primarily being studied and used for two main conditions:

  • Presbyopia: This is an age-related condition where the eyes gradually lose their ability to focus on nearby objects. It typically becomes noticeable in your 40s and continues to progress[3].
  • Headache research: Carbachol has been studied for its effects on headaches and cerebral blood flow, though this appears to be mainly in experimental research settings rather than as an approved treatment[4][1].

How Carbachol Works

Carbachol works by mimicking the action of acetylcholine in your body. In the context of eye treatment for presbyopia, it appears to work through several mechanisms:

  • It causes the pupil to constrict (become smaller), which is known as miosis. This creates a pinhole effect that increases the depth of focus in the eye, making it easier to see objects up close[3].
  • It may affect the muscles that control the shape of the lens in the eye, potentially helping with the focusing mechanism[2].

In headache research, Carbachol is being studied for its effects on blood vessels. It appears to cause changes in regional cerebral blood flow and may affect the diameter of both intracranial (inside the skull) and extracranial (outside the skull) blood vessels[4][1].

Carbachol for Presbyopia Treatment

Most of the clinical trials cited involve using Carbachol as an eye drop treatment for presbyopia. Presbyopia is the gradual loss of your eyes’ ability to focus on nearby objects. It’s a natural, often annoying part of aging that usually becomes noticeable in your early to mid-40s and continues to worsen until around age 65.

The clinical trials investigate whether Carbachol eye drops can improve near vision without significantly affecting distance vision. The primary measurement used in these studies is the improvement in near visual acuity (how well you can see objects up close) measured in ETDRS letters (a standardized eye chart)[3][2].

Specifically, researchers are looking for:

  • A gain of 15 or more ETDRS letters in near visual acuity without losing 5 or more letters in distance visual acuity[2][5].
  • Changes in pupil diameter, as the constriction of the pupil creates a “pinhole effect” that can improve near vision[3].

Carbachol in Headache Research

Some clinical trials are investigating Carbachol’s effects on headaches and cerebral blood flow. In these studies, Carbachol is administered intravenously (directly into a vein) rather than as eye drops[4][1].

The research aims to understand:

  • Whether Carbachol can induce headaches in study participants, including those with migraine[1].
  • How Carbachol affects blood flow in different parts of the brain[4].
  • Changes in the diameter of blood vessels both inside and outside the skull[1].

This research is important for understanding the mechanisms of headaches, particularly migraines, but it’s worth noting that Carbachol is not being used as a headache treatment in these studies – rather, it’s being used as a tool to study how headaches work[4].

Different Formulations

The clinical trials mention several different formulations of Carbachol:

  • Carbachol PF: A preservative-free formulation of Carbachol used as eye drops[3].
  • BRIMOCHOL PF: A combination of Carbachol and another medication called brimonidine tartrate in a preservative-free formulation[3][5].
  • BRIMOCHOL and BRIMOCHOL F: Other formulations of the Carbachol/brimonidine combination[2].

The “PF” in these names stands for “preservative-free,” which means the eye drops don’t contain additives that might irritate the eyes of sensitive individuals[5].

Clinical Studies and Research

Carbachol is being extensively studied in clinical trials for its potential in treating presbyopia. These studies typically involve:

  • Randomized, double-blind designs where neither the participants nor the researchers know who is receiving which treatment[3].
  • Comparison of Carbachol with other treatments, such as brimonidine tartrate alone or in combination (BRIMOCHOL)[2][5].
  • Measurement of changes in near and distance visual acuity at various time points after administration[3].
  • Assessment of both monocular (one eye) and binocular (both eyes) vision[3].

One particular study in Chinese patients with presbyopia is evaluating the efficacy and safety of BRIMOCHOL PF and CARBACHOL PF across multiple treatment sequences, with careful assessment of visual acuity at different time points (15 minutes, 1 hour, 2 hours, etc.) after administration[3].

Potential Side Effects

While the clinical trial data provided doesn’t explicitly list all the side effects, some potential effects can be inferred based on the drug’s mechanism of action and the parameters being monitored in the studies:

  • Changes in pupil size: Carbachol causes pupil constriction, which is actually part of how it works to improve near vision, but might affect vision in dim lighting[3].
  • Changes in distance vision: The studies specifically monitor for any decrease in distance visual acuity, suggesting this could be a concern[2].
  • Headache: In some studies, Carbachol is actually being used to induce headaches (for research purposes), so this could be a side effect when used for other purposes[4].
  • Effects on blood flow: Carbachol can affect blood vessel diameter and blood flow, which might have systemic effects beyond the eyes[1].

It’s important to note that any medication can have side effects, and the complete safety profile of Carbachol, particularly for long-term use as an eye drop for presbyopia, is still being established through these clinical trials[3][2].

Aspect Details
Primary Indications Presbyopia (age-related farsightedness), Headache research
Formulations Studied – CARBACHOL PF (preservative-free) eye drops
– BRIMOCHOL PF (combination of carbachol and brimonidine tartrate)
Administration Method – For presbyopia: Topical eye drops (typically one drop per eye)
– For headache studies: Intravenous infusion (3 microgram per kg bodyweight)
Primary Outcome Measures – Presbyopia studies: Improvement in near vision without loss of distance vision
– Headache studies: Headache response and changes in cerebral blood flow
Study Designs Primarily randomized, double-blind, crossover studies with placebo control
Assessment Timeframes Presbyopia studies measure outcomes at multiple points (15 minutes to 8 hours after administration)
Target Population – Adults with presbyopia (both phakic and pseudophakic)
– Subjects with and without migraine (for headache studies)
Mechanism of Action – Presbyopia: Pupil constriction creating a pinhole effect
– Headache: Effects on cerebral blood vessels and flow

FAQ

  • What is CARBACHOL and how does it work? CARBACHOL is a medication that acts as an analogue of acetylcholine, a neurotransmitter in the body. In eye treatments, it works by causing pupil constriction (making the pupil smaller) and affecting the eye muscles that control focusing. This pupil constriction creates a pinhole effect that can improve near vision in people with presbyopia. In headache studies, it's being investigated for its effects on blood vessels and cerebral blood flow.
  • What conditions is CARBACHOL being studied for in clinical trials? Based on the available data, CARBACHOL is primarily being studied for two conditions: presbyopia (age-related difficulty focusing on near objects) and headache. The majority of current trials focus on its use in eye drop formulations for presbyopia, while a smaller number of studies examine its effects on headache and cerebral blood flow.
  • How is CARBACHOL administered in presbyopia clinical trials? In presbyopia trials, CARBACHOL is administered as eye drops. It's being tested both as a standalone treatment (monotherapy) referred to as 'CARBACHOL PF' and in combination with another medication called brimonidine tartrate (known as 'BRIMOCHOL PF'). Typically, participants receive a single drop in each eye during study visits, and then researchers measure changes in near and distance vision at various time points after administration.
  • What results are researchers measuring in the presbyopia trials? Researchers are primarily measuring improvements in near vision without compromising distance vision. The main outcome being assessed is the proportion of participants who achieve a significant improvement in near visual acuity (typically a gain of 15 or more ETDRS letters) without losing distance vision (defined as losing fewer than 5 ETDRS letters). They also measure changes in pupil diameter, as CARBACHOL causes pupil constriction, which is part of how it improves near vision.
  • Are there any side effects or safety concerns with CARBACHOL? While the available data doesn't explicitly list side effects, the studies are designed to evaluate both safety and efficacy. CARBACHOL causes pupil constriction, which might cause temporary dimming of vision or difficulty seeing in low light. The crossover design of many studies suggests researchers are carefully monitoring tolerability. The trials include multiple measurements over time (from 15 minutes to 8 hours after administration) to track both beneficial effects and any potential adverse reactions.

Ongoing Clinical Trials on CARBACHOL

  • Study on Vascular Dysfunction: Comparing Acetylcholine Chloride and Carbachol for Forearm Blood Flow Evaluation in Patients

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Presbyopia: An age-related condition where the eye gradually loses the ability to focus on close objects. It typically becomes noticeable in one's mid-40s and continues to progress until around age 65.
  • ETDRS letters: Early Treatment Diabetic Retinopathy Study letters, which are standardized characters used to test visual acuity (sharpness of vision) in clinical settings. Gaining ETDRS letters means vision has improved.
  • MCNVA: Monocular Corrected Near Visual Acuity – a measurement of how well a person can see objects up close with one eye, while wearing any needed vision correction.
  • MCDVA: Monocular Corrected Distance Visual Acuity – a measurement of how well a person can see distant objects with one eye, while wearing any needed vision correction.
  • BCNVA: Binocular Corrected Near Visual Acuity – a measurement of how well a person can see objects up close using both eyes together, while wearing any needed vision correction.
  • BCDVA: Binocular Corrected Distance Visual Acuity – a measurement of how well a person can see distant objects using both eyes together, while wearing any needed vision correction.
  • Mesopic conditions: Lighting conditions that are between bright light (photopic) and dim light (scotopic). This represents intermediate light levels similar to dusk or dawn.
  • Emmetropic: Referring to eyes that have no refractive error and do not need corrective lenses for distance vision. Perfect or near-perfect vision without glasses or contacts.
  • Phakic: Refers to an eye that still has its natural lens (as opposed to an artificial lens implant).
  • Pseudophakic: Refers to an eye where the natural lens has been replaced with an artificial lens implant, typically after cataract surgery.
  • Cerebral Blood Flow: The blood supply to the brain in a given period of time. Changes in cerebral blood flow may be associated with headaches and other neurological conditions.
  • Double-blind: A study design where neither the participants nor the researchers know which treatment a participant is receiving, which helps prevent bias in assessing results.
  • Crossover study: A research design where participants receive different treatments in a specific sequence, allowing each person to serve as their own control.
  • BRIMOCHOL: A combination medication containing both carbachol and brimonidine tartrate, being studied for presbyopia treatment.
  • PF (Preservative Free): Refers to eye drops formulated without preservatives, which can reduce irritation for some patients, especially those with sensitive eyes.
  • Monotherapy: Treatment with a single drug, as opposed to combination therapy which uses multiple medications together.

References

  1. https://clinicaltrials.gov/study/NCT00564408
  2. https://clinicaltrials.gov/study/NCT04774237
  3. https://clinicaltrials.gov/study/NCT06948357
  4. https://clinicaltrials.gov/study/NCT00357864
  5. https://clinicaltrials.gov/study/NCT05135286